Abbott Laboratories Q2 2026 Earnings
As seen on the 24/7 Wall St. homepage on July 16, 2026.
Q2 2026
EPS
$1.31
est $1.28
+2.6%
Revenue
$12.59B
est $12.52B
+0.6%
Abbott beat on adjusted EPS and raised full-year guidance to $5.45 to $5.60 as the Exact Sciences acquisition fueled a 13% revenue surge, though continuous glucose monitor competition and a declining Nutrition business keep near-term headwinds in play.
Mentioned: ABT